2023
DOI: 10.29228/jrp.372
|View full text |Cite
|
Sign up to set email alerts
|

Novel 4-thiazolidinone derivatives bearing imidazo[2,1- b]thiazole moiety: design, synthesis, and antiviral activity evaluation

Faika BAŞOĞLU ÜNAL,
Selin CİMOK,
Efe Doğukan DİNCEL
et al.

Abstract: This paper aimed to synthesize novel compounds carrying imidazo[2,1-b]thiazole nucleus, characterize them with various spectroscopic methods, moreover evaluate their antiviral activity. All novel derivatives were evaluated for their antiviral activity against Coxsackie B4 virus, Respiratory syncytial virus, Influenza A/H1N1 virus, Influenza A/H3N2, and Influenza B virus. Some of the compounds, particularly the derivatives carrying 4methylphenyl and 4-bromophenyl moiety, exhibited higher and comparable activiti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…(Basoglu & Ulusoy Guzeldemirci, 2020;Mohamed & Abdel-wahab, 2012;Shareef et al, 2020). Along with our work (Basoglu et al, 2021;Başoğlu-ünal et al, 2023;Dincel et al, 2020;Gursoy et al, 2020;Ulusoy Guzeldemirci et al, 2019;Ulusoy Guzeldemirci et al, 2017) regarding both scaffolds, many approved drug molecules by FDA are on the market such as Triapine, thioacetazone, methisazone (Dincel et al, 2021), and levamisole (Basoglu et al, 2021) which carry either thiosemicarbazide or imidazo[2,1-b]thiazole moiety. Levamisole was approved for the first time as an anticancer drug with an imidazo[2,1-b]thiazole structure (Basoglu et al, 2021).…”
Section: Introductionmentioning
confidence: 52%
See 1 more Smart Citation
“…(Basoglu & Ulusoy Guzeldemirci, 2020;Mohamed & Abdel-wahab, 2012;Shareef et al, 2020). Along with our work (Basoglu et al, 2021;Başoğlu-ünal et al, 2023;Dincel et al, 2020;Gursoy et al, 2020;Ulusoy Guzeldemirci et al, 2019;Ulusoy Guzeldemirci et al, 2017) regarding both scaffolds, many approved drug molecules by FDA are on the market such as Triapine, thioacetazone, methisazone (Dincel et al, 2021), and levamisole (Basoglu et al, 2021) which carry either thiosemicarbazide or imidazo[2,1-b]thiazole moiety. Levamisole was approved for the first time as an anticancer drug with an imidazo[2,1-b]thiazole structure (Basoglu et al, 2021).…”
Section: Introductionmentioning
confidence: 52%
“…This difference offers to distinguish thiosemicarbazide derivatives from hydrazide. All synthesized compounds showed wide and weak bands arising from N-H around 3251-3122 cm −1 region, whereas disappearing any two sharp bands resulting from NH 2 (Başoğlu-ünal et al, 2023;Erdik, 2015). Furthermore, there is one more difference of the designed molecules have arising from thiosemicarbazide scaffold which is C=S band as well.…”
Section: Chemistrymentioning
confidence: 92%